Company: SHPH
Filing Date: 2025-01-24
Form Type: 424B3
Source: 0001493152-25-003508
Chunk: 67

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-01-24
Form: 424B3
Chunk 67
---
 notes or accompanying warrants to the extent such issuance would cause such selling stockholder, together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed 4.99% of our then outstanding shares of common stock following such conversion. The number of shares in the second column does not reflect this limitation. The selling stockholders may sell all, some or none of their shares in this offering. See “Plan of Distribution.”

| 47 |

| Name of Selling Shareholder |     | Number of Shares Owned Prior to 
 Offering                        |         |    |     | Maximum Number of Shares to be Offered       
 for the Account of the Selling Stockholder** |         |    |     | Number of Shares Owned After the 
 Offering                         |         |     | % Owned After the Offering** |      |   |
| Anatoly Dristchilo, MD      |     |                                 | 538,701 | -1 |     |                                              | 546,524 | -2 |     |                                  | 862,154 |     |                              | 20.9 | % |
| Daniel Hutt(3)              |     |                                 |       0 |    |     |                                              | 546,524 |    |     |                                  |       - |     |                              |    - |   |
| Kenneth Zuckerbrott(4)      |     |                                 |       0 |    |     |                                              | 218,610 |    |     |                                  |       - |     |                              |    - |   |
| Robert Frome(5)             |     |                                 |       0 |    |     |                                              | 208,167 |    |     |                                  |       - |     |                              |    - |   |
| Yalla Capital, LLC(6)       |     |                                 |       0 |    |     |                                              | 273,904 |    |     |                                  |       - |     |                              |    - |   |

* The percentage of ownership before the offering is calculated based on 4,076,568 shares outstanding as of January 10, 2025. The percentage of ownership after the offering assumes the issuance of all of the shares underlying the Convertible Note and Warrant that are offered for resale hereby, and the sale by such selling stockholder of all of the shares offered for resale hereby.

** All holders of convertible notes and warrants sold in the October 2024 Private Placement are subject to